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The antioxidant mechanism of ebselen in rats brain is largely linked with its glutathione peroxidase (GPx)
rather than its peroxiredoxin mimicry ability. However, the precise molecular dynamics between the
GPx-mimicry of ebselen and thiol utilization is yet to be fully clariﬁed and thus still open. Herein, we
investigated the inﬂuence of dithiothreitol (DTT) on the antioxidant action of ebselen against oxidant-
induced cerebral lipid peroxidation and deoxyribose degradation. Furthermore, the critical inhibitory
concentrations of ebselen on the activities of sulphydryl enzymes such as cerebral sodium pump, d-
aminolevulinic acid dehydratase (d-ALAD) and lactate dehydrogenase (LDH) were also investigated.
We observe that ebselen (atP42 lM) markedly inhibited lipid peroxidation in the presence and absence
of DTT, whereas it inhibited deoxyribose degradation only in the presence of DTT. Furthermore, under
in vitro conditions, ebselen inhibited the thiol containing enzymes; cerebral sodium pump (at
P40 lM), d-ALAD (P10 lM) and LDH (P1 lM) which were either prevented or reversed by DTT. How-
ever, the inhibition of the activities of these sulphydryl proteins in diabetic animals was prevented by
ebselen. Summarily, it is apparent that the effective in vitro inhibitory doses of ebselen on the activity
of the sulphydryl proteins are far less than its antioxidant doses. In addition, the presence of DTT is evi-
dently a critical requirement for ebselen to effect its antioxidant action against deoxyribose degeradation
and not lipid peroxidation. Consequently, we conclude that ebselen possibly utilizes available thiols on
sulphydryl proteins to effect its GPx mimicry antioxidant action against lipid peroxidation in rat brain
homogenate.
 2013 Elsevier Ireland Ltd. All rights reserved.1. Introduction
In the last few decades, concerted efforts have centered on the
use of selenium based compounds in the prevention and manage-
ment of oxidative stress-linked degenerative diseases. In this regard,
synthetic organoseleniums have been of prime interest due to their
promising pharmacological potentials. Ebselen (2-phenyl-1,2-ben-
zioselenazol-3(2H)-one; Scheme 1), is a synthetic selenium-contain-
ing heterocycle that has been used experimentally and clinically
with success in a variety of situations where free radicals are in-
volved and is generally regarded as non-toxic [1,2]. Basically, antiox-
idant property of ebselen has been linked mainly to its glutathione
peroxidase (GPx)- or thiol-peroxidase-like activity, suggesting that
these compounds can decompose peroxides using either reducedglutathione or other thiols as electron donors ([3–6]; Scheme 2). In
addition, literature data have also indicated that ebselen compound
can be a substrate of mammalian thioredoxin reductase (TrxR) [6,7],
which can be an efﬁcient route for selenol formation and, conse-
quently, peroxide degradation ([8,9]; Scheme 3). However, the exact
contribution of each pathway to the antioxidant properties of ebse-
len is still unknown and thus still open [9]. Hypothetically, the oper-
ation of the two routes can be considered advantageous to the living
cells, because the actual concentration of selenol is expected to be
higher when the two pathways are active.
In the present study, our prime interest is speciﬁcally on the
GPx mimicry of ebselen which is depicted in Scheme 2. This
scheme is described as a catalytic cycle in which, the Se–N bond
of ebselen is readily cleaved by thiols to produce the corresponding
selenenyl sulﬁdes, which upon reduction by excess thiols produces
selenol. Ultimately, the selenol reacts with organic hydroperoxide
to form ebselen via ebselen–selenic acid [10]. Hence, the main
cytoprotective role of ebselen is related to its GPx-like activity that
Scheme 1. Structure of ebselen.
Scheme 2. The mechanism of the catalytic reduction of hydroperoxides by ebselen
as illustrated in Nogueira and Rocha [5].
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that the presence of thiols is a critical condition for the antioxidant
action of this organoselenium [11–13]. Expectedly, this antioxidant
mechanism of ebselen should hold sway under in vitro and in vivo
systems involving its pharmacological testing. While the above
speculation seems logical and have been variedly conﬁrmed to
be true under in vitro conditions [2,3,5,14,15], however experimen-
tal data from our laboratory and elsewhere have consistently
shown that when ebselen was administered into animals either
naïve or diseased models, the pharmacological action of ebselen
was accompanied by an increase in the level of endogenous thiols
in these animals [16,17]. Thus the dynamics between endogenous
thiols and the pharmacological effects of ebselen is rather puzzling
and may suggest that in vitro and in vivo reaction mechanisms of
ebselen may differ considerably. Consequently, the antioxidant
mechanism(s) of ebselen is rather a complex phenomenon and
an enigmatic puzzle that is far from being completely understood.
Unraveling this complex molecular drama has been the driving
force in our laboratory especially in the understanding of the pre-
cise antioxidant chemistry of ebselen and other organoseleniums.Scheme 3. The peroxiredoxin mimic activity of ebselen as exempliﬁed by Nogueira
and Rocha [2,5].Recently, we attempted to protect deoxyribose sugar from Fenton
derived OH assaults using ebselen. We observed that this organo-
selenium did not offer protection against OH-induced degradation
of the pentose sugar but effectively inhibited lipid peroxidation in-
duced by various neurotoxic and hepatotoxic agents. The latter
observation is only in part conﬁrmatory of earlier reported data
[2,3,5,15]. More interestingly though is the fact that there is no
available data resolving this intriguing, yet contrasting and puz-
zling observation in the literature. In any case, an elegant scientiﬁc
explanation for the rationale behind the observed differential sen-
sitivity of ebselen in its protection of lipids and deoxyribose sugar
may provide an insight into the seemingly complex dynamics be-
tween the antioxidant action of ebselen and its inﬂuence on thiol
redox systems. However, it is noteworthy that scientiﬁc ap-
proach(es) aimed at understanding the antioxidant chemistry of
ebselen should as a necessity take into consideration its already
established GPx mimicry and the ability of this organoselenium
to serve as a substrate for TrxR. In this regard, taking into account
our recent observation indicating that ebselen is not a substrate for
the mammalian cerebral TrxR [9] thus showing that its main anti-
oxidant mechanism in the brain may be its GPx mimicry and the
fact that it inhibits cerebral lipid peroxidation but not deoxyribose
degradation, we designed several experimental models with a view
to gaining more insight into the molecular puzzles surrounding the
pharmacological chemistry of ebselen vis-a-vis its strict depen-
dence on thiols under in vitro conditions.2. Materials and methods
2.1. Chemicals
Ebselen, dithiothreitol (DTT), 5,5-dithio-bis-(2-nitrobenzoic
acid) (DTNB), and thiobarbituric acid (TBA), adenosine triphos-
phate (ATP), d-aminolevulinic acid (d-ALA), nicotinamide adenine
dinucleotide (oxidized) (NAD+) were obtained from Sigma (St.
Louis, MO). All other chemicals were of analytical grade and were
obtained from standard commercial suppliers.
2.2. Animals
Male adult Wistar rats (200–250 g) from our own breeding col-
ony were used. Animals were kept in separate animal cages, on a
12-h light: 12-h dark cycle, at a room temperature of 22–24 C,
and with free access to food and water. The animals were used
according to standard guidelines of the Committee on Care and
Use of Experimental Animal Resources.
2.3. Preparation of tissue homogenate
Rats were decapitated under mild ether anesthesia and the
brain was rapidly removed, placed on ice and weighed. Tissues
were immediately homogenized in cold 50 mM Tris–HCl, pH 7.4
(1/10, w/v). The homogenate was centrifuged for 10 min at
4000g to yield a pellet that was discarded and a low-speed super-
natant (S1). This was used for TBARS and enzyme assays. The
amount of protein in S1 was carried out by the method of Lowry
et al. [18].
2.4. Thiobarbituric acid reactive species (TBARS) assay
An aliquot of 100 ll of S1 was incubated at 37 C in the presence
of ebselen (1–167 lM) in the medium with and without DTT
(2 mM) and/or Fe2+ (10 lM) or H2O2 (2 mM) for 30, 45 and
60 min. Productions of TBARS were determined as described by
method of Ohkawa et al. [19] except that the acetate buffer for color
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adding 300 ll 8.1% SDS to S1, followed by sequential addition of
500 ll acetic acid/HCl (pH 3.4) and 500 ll 0.8% of thiobarbituric
acid (TBA). This mixture was incubated at 95 C for 1 h. TBARS pro-
ducedweremeasured at 532 nm and the absorbancewas compared
to that of a standard curve obtained usingmalondialdehyde (MDA).
2.5. Determination of thiol consumption in TBARS assay
The incubation system is essentially as described in Section 2.4
above. However, at the expiration of the incubation periods, 5% tri-
chloroacetic acid was added and centrifuged to precipitate the pro-
teins. The levels of thiols were estimated using Ellman’s reagent
following the method of Ellman [20].
2.6. Deoxyribose degradation
Deoxyribose degradation was determined as described in liter-
ature [21]. Deoxyribose is degraded by hydroxyl radicals with the
release of thiobarbituric acid (TBA) reactive materials. Deoxyribose
(3 mM) was incubated at 37 C for 30 min with 50 mM potassium
phosphate pH 7.4 plus ferrous sulphate (0.1 mM) and/or H2O2
(1 mM), ebselen (1–100 lM) and with or without DTT to induce
deoxyribose degradation. After incubation, 400 ll of TBA 0.8%
and 800 ll of TCA 2.8% were added, and the tubes were heated
for 20 min at 100 C and spectrophotometrically measured at
532 nm.
2.7. Determination of thiol consumption in deoxyribose degradation
The incubation system is essentially as described in Section 2.6.
After incubation, the levels of thiols were estimated using Ellman’s
reagent following the method of Ellman [20].
2.8. Effect of ebselen on d-ALA-D activity
d-ALA-D activity was assayed according to the method of Sassa
[22] by measuring the rate of product [porphobilinogen (PBG)] for-
mation except that 100 mM potassium phosphate buffer and
2.5 mM d-ALA were used. Incubation was carried out in the pres-
ence and absence of DTT. An aliquot of 100 ll of S1 was incubated
for 1 h at 37 C and the reaction product was determined using
modiﬁed Erhlich’s reagent at 555 nm.
2.9. Effect of ebselen on LDH activity
LDH activity was monitored spectrophotometrically by the rate
of increase in absorbance at 340 nm at 35 C resulting from forma-
tion of NADH. The assay medium contained 21 mM of glycine-KOH
buffer (pH 10), 0.25 mM of NAD+, ebselen (1–10 lM) and 15–20 lg
of protein. The mixture was preincubated for 3 min, and the reac-
tion was started by adding neutralized lactic acid (pH 6.8) to pro-
vide a ﬁnal concentration of 50 lM. Incubation was carried out in
the presence and absence of DTT. Values are expressed as change in
absorbance/mg protein/min.
2.10. Effect of ebselen on Na+/K+-ATPase activity
The reaction mixture for Mg2+-dependent-Na+/K+-ATPase activ-
ity assay contained 3 mM MgCl, 125 mM NaCl, 20 mM KCl and
50 mM Tris–HCl, pH 7.4 and 100–120 lg of protein, in a ﬁnal vol-
ume of 500 ll. The reaction was initiated by addition of ATP to a
ﬁnal concentration of 3.0 mM. Controls were carried out under
the same conditions with the addition of 0.1 mM ouabain. Na+/
K+-ATPase activity was calculated by the difference between the
two assays. Released inorganic phosphorous (Pi) was measuredby the method of Fiske and Subbarow [23]. Incubation was carried
out in the presence and absence of DTT. For all enzyme assays,
incubation times and protein concentration were chosen to ensure
the linearity of the reactions. All samples were run in duplicate.
Controls with the addition of the enzyme preparation after mixing
with trichloroacetic acid (TCA) were used to correct for nonenzy-
matic hydrolysis of substrates. Enzyme activity was expressed as
nmol of phosphate (Pi) released min1 mg protein1.
2.11. Thiol peroxidase activity
The catalytic effect of ebselen on the reduction of H2O2 was car-
ried out in the presence of DTT. Free –SH groups were determined
according to Ellman [20]. Ebselen at a concentration range of 50–
150 lM were incubated in the medium containing DTT (2 mM)
with and without H2O2 (2 mM) at 2.5 min intervals for 15 min. Ali-
quots of the reaction mixture (200 ll) were checked for the
amount of DTT at the indicated time intervals.
2.12. Diabetes induction
Diabetes was induced by a single intravenous injection of STZ
(50 mg/kg) previously diluted in 0.1 M citrate-buffer (pH 4.5) into
adult male mice. Control rats received an equivalent amount of
buffer. Diabetic state was checked 72 h after induction with STZ.
Animals were considered diabetic when blood glucose level ex-
ceeded 250 mg/dL.
2.13. Treatment
The animals were divided randomly into the following groups:
(group 1) control; (group 2) ebselen; (group 3) STZ; and (group 4)
STZ + ebselen. Groups 2 and 4 were administered ebselen by ga-
vage at a dose of 1 mg/kg (once/day) for 21 days after the adminis-
tration of STZ. At the end of the experimental period, diabetic mice
and the corresponding control animals were anesthetized with
ether and euthanized by decapitation. Mice were fasted 12 h prior
to euthanasia.
2.14. Ex vivo enzyme assay
Na+/K+-ATPase, d-ALA-D and LDH activities were assayed as de-
scribed above except that no preincubation was carried out.
2.15. Non-protein thiol assay
Non-protein thiols levels were estimated using Ellman’s reagent
after deproteinization of selected tissue with trichloroacetic acid
(TCA) (5% in 1 mmol EDTA) by the method of Ellman [20].
2.16. Statistical analysis
All values obtained were expressed as mean ± SEM. The data
were analyzed by appropriate ANOVA followed by Duncan’s multi-
ple range tests where appropriate and this is indicated in the text
of results. The differences were considered signiﬁcant when
p < 0.05.
3. Results
3.1. General observation
We would like to state that for lipid peroxidation experiments,
incubations were done at 30, 45 and 60 min and similar results
were obtained. In fact, there were no statistical differences in the
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description below, we have simply described the data obtained
for incubation time of 60 min.3.2. Ebselen vs. Fe2+-induced cerebral TBARS production vs. thiol
utilization
Fig. 1 shows the antioxidant behavior of ebselen under basal
and Fe2+-induced cerebral lipid peroxidation in the absence and
presence of the dithiol, DTT (panel a). In order to better explore
the data obtained, separate statistical analysis were carried out.
One-way ANOVA revealed that ebselen exerted marked inhibitory
effect on the production of lipid peroxidation products from rats’
brain irrespective of the incubation conditions. In fact, three way
ANOVA [(with or without thiols)  (basal/Fe2+-induced)  5 con-
centrations of ebselen] yielded signiﬁcant third order interactions
(p < 0.001). The interaction is signiﬁcant because ebselen exerted
marked inhibitory effect on the lipid peroxidation process either
in the presence or absence of the dithiol. Furthermore, it is of note
that the antioxidant potency is independent of the different incu-
bation times employed.
Analysis of the DTT utilization by ebselen showed that the orga-
noselenium depleted the levels of DTT (Fig. 1 panel b) in a concen-
tration dependent manner. This effect appears to be independent
of the presence of Fe2+. Three way ANOVA [(with or without thi-
ols)  (basal/Fe2+-induced)  5 concentrations of ebselen] of the
results obtained revealed a marked third order interaction
(p < 0.0005). This interaction is signiﬁcant because ebselen pro-
foundly depleted the level of the thiols in a concentration depen-
dent manner.3.3. Ebselen vs. H2O2-induced cerebral TBARS production vs. thiol
utilization
When H2O2 was used to induce lipid peroxidation, ebselen
caused a concentration dependent inhibitory effect on the produc-
tion of lipid peroxidation products in the rats’ brain in a fashion
similar to that observed when Fe2+ was used as prooxidant
(Fig. 2 panel a). One-way and three-way ANOVA performed on
the results obtained showed a strongly marked interaction because
H2O2 markedly exacerbated the production of aldehydic products
from cerebral lipids and ebselen markedly inhibited this effect.
This inhibitory effect of ebselen is independent of the availability
of the DTT whether in the basal or H2O2 induced lipid peroxidation.
Consequently, we equally observed that the antioxidant effect of0 40 80 120 160
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Fig. 1. (a) Effect of ebselen on lipid peroxidation in the presence and absence of Fe2+ wit
and absence of Fe2+ in brain tissue homogenate. Data showmean ± SEM values average fro
are presented as mean ± SEM and post hoc comparisons were done by Duncan’s multipebselen was accompanied by a concomitant reduction in the levels
of DTT (Fig. 2 panel b).3.4. Ebselen vs. free radical scavenging, Fe2+-chelating and reducing
properties
Fig. 3 shows the free radical scavenging property (panel a), Fe2+-
chelating (panel b) and reducing properties (panel c) of ebselen. As
can be observed, ebselen neither exerted free radical scavenging
ability nor Fe2+ chelating nor reducing properties.3.5. Thiol peroxidase activity of ebselen
The oxidation of DTT by DPDS in the absence of peroxide was
similar for control (no ebselen; data not shown for control); how-
ever, in the presence of hydrogen peroxide, the oxidation of DTT
was signiﬁcantly higher in the presence of 100 lM ebselen during
all the sampling period (Fig. 4). Two-way ANOVA [(with and with-
out H2O2)  (seven sampling times)] indicate that the rate of DTT
oxidation oxidation in the absence of peroxide was similar for con-
trol (no ebselen. However, in the presence of hydrogen peroxide,
the oxidation of GSH was signiﬁcantly higher in the presence of
ebselen during all the sampling periods.3.6. Ebselen vs. Fe2+/H2O2-induced deoxyribose degradation vs. thiol
utilization
Fig. 5(a–d), shows the results obtained when deoxyribose sugar
was assaulted by Fe2+ and/or H2O2 in the absence and presence of
DTT. Apparently, ebselen alone did not exert any signiﬁcant inhib-
itory effect on basal production of aldehyde products from degra-
dation of deoxyribose sugar (Fig. 5 panel a). In the presence of
DTT, however, ebselen showed a concentration dependent inhibi-
tion of TBARS production evoked by H2O2 (panel b), Fe2+ (panel
c) and combination of H2O2/Fe2+ (panel d). In fact, separate
three-way ANOVA [(with or without thiol)  (with or without
Fe2+ or H2O2)  5 concentrations of ebselen] yielded a signiﬁcant
third order interaction (p < 0.0001) because ebselen exhibited a
marked concentration dependent inhibitory effect on the produc-
tion of TBARS from deoxyribose degradation. In Fig. 6, the amount
of DTT left during the deoxyribose assay was quantiﬁed for the var-
ious incubation conditions. The data shows that the levels of the
thiols were markedly reduced and this effect is related to the abil-
ity of the ebselen to inhibit the Fenton process.0 40 80 120 160
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Fig. 2. (a) Effect of ebselen on lipid peroxidation in the presence and absence of H2O2 with and without DTT. (b) Effect of ebselen on the oxidation of DTT in the presence and
absence of H2O2 in brain tissue homogenate. Data show mean ± SEM values average from four independent experiments performed in quadruplicate in different days. Data
are presented as mean ± SEM and post hoc comparisons were done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in relation to the control (p < 0.05).
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Fig. 3. (a) DPPH radical scavenging ability of ebselen. (b) Fe2+ chelating ability of ebselen. (c) Reducing property of ebselen. Data show mean ± SEM values average from four
independent experiments performed in quadruplicate in different days. Data are presented as mean ± SEM and post hoc comparisons were done by Duncan’s multiple range
test.
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Fig. 4. GPx mimic of ebselen using DTT as the thiol source. Data show mean ± SEM
values average from four independent experiments performed in quadruplicate in
different days. Data are presented as mean ± SEM and post hoc comparisons were
done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in relation to
the control (p < 0.05).
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Fig. 7 shows that ebselen caused a concentration dependent
inhibition on the activity of cerebral d-ALAD. At 100 lM, the orga-
noselenium completely inhibited the activity of the enzyme. Con-
versely, pre and post incubation of enzyme with DTT markedly
abolished the inhibitory effect of ebselen on the activity of the en-
zyme (p < 0.05).3.8. Effect of ebselen on the activity of LDH
Ebselen caused a signiﬁcant concentration dependent inhibition
on the activity of LDH which was signiﬁcant at 1 lM (Fig. 8). DTT
on the other hand prevented and reversed the inhibition caused
by ebselen (p < 0.05).
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Fig. 5. Inﬂuence of the dithiol (DTT) on the inhibitory effect of ebselen on deoxyribose degradation: in the presence of ebselen alone (a); in the presence of Fe2+ alone (b); in
the presence of H2O2 alone (c) and in the presence of both Fe2+ and H2O2. Data show mean ± SEM values average from four independent experiments performed in
quadruplicate in different days. Data are presented as mean ± SEM and post hoc comparisons were done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in
relation to the control (p < 0.05).
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Fig. 6. Effect of ebselen on DTT oxidation in OH–induced deoxyribose degradation.
Data show mean ± SEM values average from four independent experiments
performed in quadruplicate in different days. Data are presented as mean ± SEM
and post hoc comparisons were done by Duncan’s multiple range test. ⁄Indicate a
signiﬁcant difference in relation to the control (p < 0.05).
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Fig. 9 shows that ebselen caused a marked inhibition on the
activity of the cerebral sodium pump. On the other hand, pre and
post treatment of enzyme with DTT markedly (p < 0.05) relieved
the inhibition of the cerebral pump imposed by ebselen treatment.
3.10. Ex vivo effect of ebselen
Fig. 10 shows that in the brain of animals treated with ebselen
oxidative stress caused a decrease in the level of thiol-containing
enzymes tested, ebselen markedly restored the activity of these en-
zymes as demonstrated for cerebral Na+/K+-ATPase (panel a), LDH
(panel b) and d-ALA-D (panel c).3.11. Effect of ebselen on non-protein thiols level in mice
The levels of non-protein thiols as expressed as GSH equivalent
in both naïve and diabetic animals is presented in Fig. 11. The non-
protein thiols levels in all the animals treated with ebselen were
markedly higher (p < 0.05).4. Discussion
One of the central antioxidant mechanisms of ebselen is cen-
tered on its GPx mimic (Scheme 2) and this has been attributed
to its numerous pharmacological actions [2,3,5,14,15]. Thus the
antioxidant action of ebselen whether in vitro or in vivo should
be accompanied with oxidation of thiols. However, under in vitro
assay conditions, exogenous thiols are often not components of
the reacting systems involving ebselen antioxidant action, thus
raising a complex puzzle. Herein, considering the inhibitory pat-
tern of ebselen on Fe2+ and H2O2-induced cerebral lipid peroxida-
tion, we observed that in the absence and presence of DTT,
ebselen inhibited cerebral lipid peroxidation either in the basal
or Fe2+ or H2O2-induced oxidative assaults with equal potency
(Figs. 1a and 2a). As observed, ebselen inhibited lipid peroxidation
in the absence of the dithiol, and thus we speculate that there is a
possibility that the antioxidant action of ebselen is not strictly
dependent on the availability of the dithiol. It may also imply that
ebselen probably exhibits a GPx and non-GPx-mimic dual antioxi-
dant mechanisms. The latter is further buttressed by our observa-
tions as presented in Figs. 1b and 2b where we observed that the
utilization of DTT by ebselen under basal and prooxidant induced
lipid peroxidation is similar suggesting a possible disconnect be-
tween the DTT oxidation and antioxidant action of ebselen. Con-
versely, the fact that ebselen neither exhibit radical scavenging
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Fig. 7. Effect of ebselen on the activity of d-aminolevulinic acid dehydratase. (a) Reaction was started by addition of d-ALA after 10 min of pre-incubation in the presence
ebselen. (b) Reaction was started by addition of d-ALA after 10 min of preincubation in the presence of ebselen and DTT. (c) Reaction was started by addition of d-ALA and DTT
after 10 min of preincubation in the presence of ebselen. Data show mean ± SEM values average from four independent experiments performed in quadruplicate in different
days. Data are presented as mean ± SEM and post hoc comparisons were done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in relation to the control
(p < 0.05).
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Fig. 8. Effect of ebselen on the activity of lactate dehydrogenase. (a) Reaction was started by addition of NAD+ after 10 min of pre-incubation in the presence ebselen. (b)
Reaction was started by addition of NAD+ after 10 min of preincubation in the presence of ebselen and DTT. (c) Reaction was started by addition of NAD+ and DTT after 10 min
of preincubation in the presence of ebselen. Data showmean ± SEM values average from four independent experiments performed in quadruplicate in different days. Data are
presented as mean ± SEM and post hoc comparisons were done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in relation to the control (p < 0.05).
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Fig. 9. Effect of ebselen on the activity of cerebral sodium pump. (a) Reaction was started by addition of ATP after 10 min of pre-incubation in the presence ebselen. (b)
Reaction was started by addition of ATP after 10 min of preincubation in the presence of ebselen and DTT. (c) Reaction was started by addition of ATP and DTT after 10 min of
preincubation in the presence of ebselen. Data show mean ± SEM values average from four independent experiments performed in quadruplicate in different days. Data are
presented as mean ± SEM and post hoc comparisons were done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in relation to the control (p < 0.05).
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Fig. 10. Effect of ebselen on the activities of cerebral sodium pump (a); d-aminolevulinic acid dehydratase (b); and lactate dehydrogenase (c) in streptozotocin-induced
diabetic rats. Data show mean ± SEM values average from four independent experiments performed in quadruplicate in different days. Data are presented as mean ± SEM and
post hoc comparisons were done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in relation to the control (p < 0.05).
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Fig. 11. GSH level in streptozotin-induced diabetic rats. Data show mean ± SEM
values average from four independent experiments performed in quadruplicate in
different days. Data are presented as mean ± SEM and post hoc comparisons were
done by Duncan’s multiple range test. ⁄Indicate a signiﬁcant difference in relation to
the control (p < 0.05).
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strongly suggest that the GPx mimic of ebselen (Fig. 4) is key to
its antioxidant action. Aside lipid peroxidation, we also attempted
to use ebselen to protect deoxyribose degradation mediated by hy-
droxyl radicals generated via Fenton reaction. Herein it is striking
to observe that ebselen alone did not protect OH assault on deoxy-
ribose sugar in the absence of DTT. On the other hand, it markedly
inhibited OH assaults on the pentose sugar in the presence of the
dithiol (Fig. 5c and d). The fact that this latter effect was accompa-
nied by marked concomitant depletion of DTT in the reaction tubes
(Fig. 6) indicate that the molecular events associated with the ob-
served differential antioxidant sensitivity of ebselen in the pres-
ence and absence of DTT in models of Fenton reaction – derived
OH assaults on cerebral lipids and deoxyribose sugar is rather an
intriguing complex phenomenon. However, thus far and consider-
ing Figs. 5 and 6, we can reasonably and safely conclude that the
antioxidant mechanism of ebselen is strictly based on its GPx mi-
mic, since it appear that the inhibition of deoxyribose degradation
elicited by ebselen is strictly dependent on the presence of DTT.
However, the antioxidant action of ebselen even in the absence
of DTT in lipid peroxidation (Figs. 1a and 2a) is in sharp contrast
with Fig. 5, where deoxyribose sugar was not prostected in the ab-
sence of the thiol. With regards to this observation we speculate
that free endogenous thiols derived from the tissue homogenates
may play a role. In this case, considering the low level of these
endogenous thiols [estimated value: 0.2 lmol GSH/in reaction
tube; or 20 lmol GSH/g tissue], we speculate that the utilization
of these thiols by ebselen must be associated with highly efﬁcient
thiol recycling system which is not supported by Scheme 2, thus
making this possibility unlikely.
It is noteworthy however, that our group and others have
shown that aside its classical GPx mimicry, ebselen can also be
metabolized by TrxR to form selenol intermediates which possibly
mediates its diverse pharmacological mechanisms [5–7,9]. In fact,
ebselen have been shown to be good substrates of rat liver, Esche-
richia coli, human placenta and calf thymus TrxR [6]. Conse-
quently, it has been strongly postulated that the TrxR-like (that
is the ability of TrxR to form the selenol intermediate of ebselen)
is more important than the glutathione peroxidase-like activity
of ebselen [9,24]. Plausible as these ﬁndings may have contributed
to our understanding of the antioxidant mechanisms of ebselen,
more recent observation in our group have shown that ebselen is
not a substrate for the rat brain TrxR [9]. Hence, it is apparent that
ebselen action in the rat brain is strictly based on the classical GPx
mimic (Scheme 2). Thus in the present study, we speculate that in
assay conditions in which exogenous dithiol were not added, then
the other possible source of thiols must necessarily be the proteinsderived from the tissue homogenates. Our earlier data [25–27]
which is also conﬁrmed herein show that ebselen inhibited thiol
containing proteins such as d-ALA-D (Fig. 7), LDH (Fig. 8) and
Na+/K+-ATPase (Fig. 9) and this fact is further conﬁrmed by the fact
that DTT prevented this inhibition. Therefore, we speculate that in
the absence of exogenous thiols and under basal or prooxidant in-
duced cerebral lipid assaults (Figs. 1a and 2a), the observed antiox-
idant action of ebselen is likely at the expense of free varieties of
endogenous thiols and available free thiols on proteins and these
thiols are strongly essential to the normal functioning of these sul-
phydryl enzymes. In consonant with our argument, earlier report
have suggested that unlike the native GPx, the redox cycle of ebse-
len is not strictly dependent on GSH and as such ebselen is not a
high-ﬁdelity mimic of GPx and can alternatively utilize a range of
structurally diverse thiol containing molecules [28] and in this in-
stance, we speculate its utilization of free available thiols on sul-
phydryl proteins to mediate its generally observed antioxidant
action under in vitro conditions in the tissue homogenates. This
phenomenon in the case of enzymes eventually leads to the loss
of activity by the proteins and a reduction of hydroperoxides.
Hence in order to explain the observed antioxidant effect of
ebselen in Figs. 1a and 2a, we will substantiate our arguments on
two premises mainly centering on the proteins as the sources of
thiol for GPx-mimicry of ebselen action under in vitro conditions.
First, there is a strong concentration overlap between the effective
pharmacology (antioxidant) (42 lM) and toxicity (for d-ALA-D,
ebselen is markedly toxic at 10 lM; for LDH at 1 lM and for
Na+/K+-ATPase at 40 lM) of ebselen, suggesting that ebselen possi-
bly mediates its antioxidant action via its toxicity, with the toxico-
logical effect preceeding its antioxidant effect. Furthermore, as
earlier mentioned, under basal conditions, the thiol consumption
of ebselen is similar to that when Fe2+ and H2O2 are employed to
induce lipid peroxidation (Figs. 1b and 2b). Based on the report
of Borges et al. [27], and our present data which in part is conﬁrma-
tory, we logically conclude that in the absence of supplied exoge-
nous thiols, when ebselen was added to the basal tissue
homogenates, it attacks thiols of importance on biological proteins
thus expressing its toxicity, and the introduction of exogenous thi-
ols only serve to relieve this inhibitory effect of ebselen on the pro-
teins. Consequently, the observed depletion of DTT in the basal
homogenate indicates that this dithiol was probably oxidized in
an attempt to salvage sulphydryl biological proteins previously
inactivated by ebselen (Figs. 7–9). Consequently, guided by our
present data, we hypothesize that the celebrated in vitro antioxi-
dant effect of ebselen in brain homogenate is a pseudo-effect and
highly misleading and consequently as depicted in Scheme 4, we
propose for the ﬁrst time a likely link between thiol mediated
in vitro toxicity and pharmacology of ebselen in brain homogenate.
The proposition of Scheme 4 may naturally pose a worry since
ebselen is already undergoing clinical trials and has exhibited pro-
found pharmacological promise in adverse neurological situations.
However reports [16,17] and current data (Figs. 10 and 11) have
shown that administration of ebselen into animals is always associ-
ated with an elevated amount of thiols strongly suggesting that the
antioxidant mechanism of ebselen under in vivo conditions is prob-
ably not associated with its generally accepted classical GPxmimic.
Consequently, we further speculate that there is an apparent dis-
connect between the observed antioxidant mechanisms of ebselen
under in vitro and in vivo conditions. Apparently, the initial testing
and eventual use of ebselen appear to have been a case of ‘‘good
chance’’ since its observed in vitro action which was the likely pre-
mise for its further testing in vivowas erroneous and disingenuous.
Therefore, this report opens a challenge to experts in organosele-
niums research to devise a holistic methodology for the evaluation
of organoseleniums for their well observed in vitro antioxidant
effects that is translatable in vivo. In our opinion, this would require
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Scheme 4. Proposed in vitro ambivalent model for the antioxidant action of ebselen mediated by its toxicity.
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delicate balance between their toxicology and pharmacology. An-
other approach is to sensitize experts in the ﬁeld of organoselenium
synthesis to devise a critical approach in the rational designs of
organoseleniums to incorporate conditions for their sensitivity to-
wards dangerous biological oxidants and less sensitive to thiols.
Again since there is possible discrepancies between the in vitro
and in vivo data associated with ebselen’s action, we hypothesize
that under in vivo conditions, there is likely existence of intermedi-
atemetabolic product(s) of this compound that possess potent anti-
oxidant property and with diverse antioxidant mechanisms which
will deﬁnitely exclude the GPx mimic. Another possibility is that
ebselen or its metabolic products possibly up-regulated the path-
ways of thiols biosynthesis under in vivo conditions. Consequently,
identiﬁcation of these metabolites may open a new exciting ﬁeld in
the rational design of organoselenium compounds that are potent
candidates in the management of oxidative stress related diseases.
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